Objective: Transcriptional regulatory elements in the ameloblastin (AMBN) promoter indicate that adipogenesis may influence its expression. 
Introduction
Multipotent mesenchymal progenitor cells may differentiate into mineralizing osteoblast or adipocyte cells (Nombela-Arrieta et al., 2011; Pittenger et al., 1999; Sadie-Van Gijsen et al., 2013) . Stromal cells, human mesenchymal stem cells (hMSC) , and osteoblasts are all found to express AMBN (Tamburstuen, Reseland et al., 2011) . Recombinant AMBN has effects on both cell proliferation as well as differentiation of hMSC (Tamburstuen et al., 2010) . Despite markedly different characteristics, the differentiation of both osteoblasts and adipocytes are modulated by peroxisome proliferation activated receptor gamma (PPARg) (Kawai and Rosen, 2010) . PPARg is a principal regulator of adipogenesis (Kawai and Rosen, 2010; Spiegelman, 1998; Wu et al., 1996; Wu et al., 1995) , and this transcription factor controls multiple regulatory domains located upstream of the AMBN gene (Tamburstuen, Snead et al., 2011) . However, to the author's knowledge, there are no scientific literature investigating the expression and role of AMBN in adipose tissue.
Adipose tissue expresses and secretes several hormones with importance for endocrine functions (Kershaw and Flier, 2004) . These hormones are involved in regulation of intake of nutrients (leptin), control of insulin, inflammation (TNFa, IL-6, resistin, adiponectin) (reviewed in (Coelho et al., 2013) ), and blood pressure (Fyhrquist et al., 1995) . Several of the so-called adipokines, like leptin (Gordeladze et al., 2002; Reseland et al., 2001) , adiponectin (Berner et al., 2004) and resistin (Thommesen et al., 2006) are found to be expressed in bone cells, and to have effects on mineralization. AMBN is processed into two temporally differently expressed splice variants in enamel, of which only the shortest variant seem involved in non-mineralizing cells. This short variant encodes AMBN that consist of the C-terminus part (Lee et al., 2003; Ravindranath et al., 2007) . During enamel biomineralisation, the long splice variant is expressed and proteolytically processed (Chun et al., 2010; Geng et al., 2015; Iwata et al., 2007) into other Nand C-terminus products Vymetal et al., 2008) , of which only the N-terminus is found in finalized enamel (Castiblanco et al., 2015) . The processing of AMBN and its dominating products are likely to determine its effect on cells. The present study suggests that AMBN is expressed in adipocytes as an early variant that include the C-terminus part of the molecule.
Materials and methods

Recombinant AMBN and AMBN fragments
Recombinant proteins were expressed in and purified from Escherichia coli (E. coli). A cleavable tobacco virus etch virus (TEV) specific peptide at the 5'end downstream of thioredoxine (TRX) allowed cleavage of rAMBN from the AMBN-TRX fusion protein, and a 6 x poly-Histidine peptide at the 3'end, as described by Wald et al. (Wald et al., 2013) . rAMBN protein includes the amino acids (aa) 27e447 (numbering accounting also for the signal peptide). The N-terminus protein includes the region aa 27e222, and the C-terminus protein includes aa 223e447. rAMBN protein used in proliferation experiments was expressed in E. coli with TRX at the N-terminus and with a 6 x polyhistidine tag in the C-terminus (Nakamura et al., 2006) . Fig. 1 present an overview of the recombinant proteins used and the location of the splice variant within the exon organization. 
Cell cultures and tissues
Sections of subcutaneous adipose female tissue were purchased from Zyagen (San Diego, CA, USA). Tissue samples of subcutaneous adipose tissue from healthy donors (aged 36, 50 and 61 years) undergoing mamma-plastic surgeries were isolated by liposuction and RNA isolated. Informed consent were provided by the donors for the storage and collection of adipose tissue (Szoke et al., 2012) .
Various cell types were used as positive control in the evaluation of AMBN expression: CD34þ precursor cells were isolated from human bone marrow with approved by the regional ethics committee for medical research and isolated as described previously (Tamburstuen, Reseland et al., 2011) . The culturing of human pulp cells (pulpa) (Dominion Pharmakine), differentiation of peripheral blood mononuclear cells into human osteoclast cells (hOC) and the analysis of gene expression were performed as described by Tamburstuen and co-workers (Tamburstuen, Reseland et al., 2011) .
Pre-adipocytes (Pt-5001; Lonza, Walkersville, MD, USA) were seeded in a concentration of 5 Â 10 4 cells/ml in 12 well plates in pre-adipocyte Growth Medium (GM)
supplemented with fetal bovine serum, L-glutamine, penicillin/streptomycin (PT-8002; Lonza). Adipogenic differentiation media were prepared from GM supplemented with insulin, dexamethasone, isobutyl-1-methylxanthine (PT-9502; Lonza) (Diff) according to the manufacturer's instructions. As dexamethasone is a strong influencer of PPARg (Gimble et al., 1996) , the effects of AMBN on PPARg expression was evaluated on cells incubated with adipogenic differentiation media without dexamethasone (Diff -dexa). Cells were grown to 100 % confluence and media was changed to GM, Diff, or Diff-dexa and 0.21 mM rAMBN, N-terminus, or C-terminus, respectively, were administrated. Untreated cells maintained in Diff-dexa or Diff were used as controls for each time-point depending on experimental conditions. 3T3-L1 cells were seeded out in a concentration of 0.5 Â 10 6 cells/ml in 12 and 48 well plates in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10 % fetal bovine serum, L-Glutamine, and penicillin/streptomycin. Cells were differentiated with DMEM supplemented with 20 % fetal bovine serum, 1 mM dexamethasone, 0.5 mM 3-isobutyl-1-methylxantine (IMBX), and 2 mM Insulin (Diff).
Untreated cells grown in DMEM supplemented with 0.2 mM insulin were used as controls for each time point (the various concentration used here are based on those presented in a review of differentiation protocols of pre-adipocytes (Scott et al., 2011) ). 
Proliferation assay
mRNA isolation
Adipocytes were washed with cold PBS, lysed, and mRNA isolated using magnetic beads (Oligo(dT) 25 Dynabeads; Ambion, Life technologies, Oslo, Norway) according to manufacturer's instructions. The RNA concentration was measured on a nanodrop spectrophotometer ND-1000 with software version 3.3.1. Isolated cDNA from human subcutaneous tissue was purchased from Zyagen (San Diego, CA, USA).
Real-time PCR
cDNA was generated from 1 ng mRNA using revertaid First Strand cDNA synthesis kit (Fermentas, Burlington, Ontario, Canada) according to manufacturer's instructions. Real-time PCR (RT-PCR) amplified cDNA for 40 cycles in 20 ml containing SYBRGreen Supermix (Bio-rad, Hercules, CA, USA, Cat.no: 1725272) on the CFX ConnectÔ system with the Bio-Rad CFX Manager software version 2.1. DDCT values of AMBN, leptin, and PPARg were normalized to GADPH and beta-actin as reference genes. Primer sequences are given in Table 1 .
Immunofluorescence
Formalin-fixed, paraffin-embedded human adipose tissue sections (AMSBio, UK)
were deparaffinized through xylene and ethanol series. Epitopes were retrieved with 10 mM citrate buffer pH 6.0 according to the antibody supplier's protocol Triton X-100 for 5 min, washed with PBS and blocked with 10% normal goat serum (NGS) and 0.1% Triton X-100 in PBS for 1h, and incubated at 4 C overnight with the primary antibodies. Sections were then washed three times with PBS before incubated to fluorophore-conjugated secondary antibodies goat anti-mouse Alexa488
and goat anti-rabbit Alexa568 (ThermoFisher), both were diluted 1:400 in 3%
NGS in PBS prior to incubation. After 4 h incubation, the sections were washed three times with PBS, incubated with 300 nM DAPI for 30 min, and mounted with Prolong Antifade (ThermoFisher). Sections prepared without primary antibodies were used as controls.
Immunofluorescent staining were examined in a Leica SP8 upright confocal microscope fitted with HyD and PMT detectors, using oil immersion objective 40x HC PL Apo CS2 40x/1.3. Excitation laser lines at 405, 488 and 552nm were used for DAPI, Alexa488 and Alexa568 respectively. Images were produced for publication using FIJI (Schindelin et al., 2012) .
Oil Red O staining
Cells were washed with cold phosphate buffered saline (PBS) and fixed with 10 % formaldehyde in PBS in 15 min, before staining with Oil-red-O (3 mg/ml in isopropanol) for 1 h. Remaining Oil Red O solution was then removed and cells were washed with distilled water. Images were taken prior to Oil Red O stain extraction by 100 % isopropyl alcohol. Extracted stain was quantitated at 490 nm. Untreated cells were counter stained with hematoxylin (Merck, Darmstadt, Germany).
Enzyme Linked Immuno Sorbent Assay
Enzyme Linked Immuno Sorbent Assay (ELISA) (Wuhan EIAAB Science Co., LTD. Cat.no UCL-E14174h, East Lake Hi-Tech Development Zone, Wuhan, 430075, China) was used to detect AMBN in 5 x concentrated medium from differentiating adipocytes.
Results
Adipocytes express AMBN mRNA
Human adipose tissue were found to express AMBN mRNA ( Fig. 2A) , The AMBN product from human adipose tissue had similar size as the products found in human pulpal cells (Pulp), human osteoclasts (hOC) and in CD 34þ progenitor cells from human bone marrow (Fig. 2B) . The mRNA of a short AMBN splice variant was also identified in human adipose tissue (Fig. 2C) .
In differentiating 3T3-L1 cells, the expression of AMBN was found to be increased concomitant to an increase in mRNA expression of PPARg and leptin. The increase, presented as mean of 3 individual experimental setups, failed to be significant (Fig. 3) .
Adipocytes express an AMBN C-terminus variant
Antibodies against the C-terminal AMBN stained the rim of subcellular compartments in mature subcutaneous adipose tissue (Fig. 4B) . The merged signals show partly co-localization with the signal against leptin antibodies (Fig. 4C ). In contrast, we were not able to produce images with sufficiently high contrast to identify the signal from the N-terminus antibodies above the background auto fluorescence (Fig. 4K and L, respectively). The expression pattern stained by leptin antibody was in cytosol and around the fixated lipid droplets (Fig. 4D ).
AMBN affect cell proliferation and the expression of adipogenic marker and transcription factors
Full-length rAMBN reduced the proliferation of 3T3-L1 cells with 20 % compared to control (P ¼ 0.007) at day 1 (Fig. 5) . Only moderate effects of rAMBN (Fig. 6A) , N-terminus (Fig. 6B) , and C-terminus (Fig. 6C ) could be observed on the accumulation of triglyceride droplets, identified with Oil Red O (Fig. 6H ) in human pre adipocytes compared to control (Fig. 6D) . rAMBN enhanced the expression of PPARg in human pre-adipocyte cells (P ¼ 0.0004) by 1.5 fold (Fig. 6E) . In contrast, the N-terminus part reduced the PPARg expression (P ¼ 0.009) with 20 % compared to control (Fig. 6G) . AMBN enhanced the expression of PPARg at day 4 in preadipocytes during differentiation supported by dexamethasone, but the data failed to be significant (data not shown). AMBN could not be detected in the cell culture media collected during differentiation of human adipocytes within the sensitivity range of the ELISA method used.
Discussion
We here present evidence for expression and regulation of AMBN in human adipose tissue, human preadipocytes, and the 3T3-L1 cell line, suggesting a putative role for this molecule in adipogenesis. The expression of AMBN was found to be enhanced during differentiation to mature adipocytes, and administration of rAMBN was found to enhance the expression of PPARg and inhibited the proliferation of 3T3-L1 cells. In mature adipose tissue, a short splice variant (À45 bp) of the C-terminus part of AMBN was also detected. The expression of a short splice variant and the C-terminus variant is similar to the expression pattern of AMBN in the early phases of enamel secretion. In the early secretion to maturation phase, ameloblast cells express the same short AMBN splice variant as found here and secrete a smaller 37 kDa Controls: Dapi (F), secondary antibody (G and H) (as in B and C respectively), merged (I), brigthfield (J), N-terminus (high exposure) (K), and secondary antibody (high exposure related to N-term) (L).
AMBN C-terminal protein, while the larger 60e70 kDa size secreted protein is expressed in late maturation, concomitant with expression of the long splice variant (Lee et al., 2003; Ravindranath et al., 2007) . It can only be speculated that these AMBN C-terminus variants found in non-mineralizing ameloblast and soft-tissue share similar roles, as both are identified in conjunction with a short splice variant, and recombinant AMBN proteins decrease proliferation of ameloblast as well as adipocytes.
PPARg expression was enhanced by administration of full-length rAMBN in differentiating adipocytes. Previously, full-length AMBN was found to induce the expression of STAT genes signaling in mesenchymal progenitor cells (Tamburstuen et al., 2010) . STAT-1, that was found upregulated, are in the JAK-STAT signaling pathway involved in regulating lipid turnover in adipocyte cells (Richard and Stephens, 2014) . JAK-STAT signaling occurs by cytokine receptors, yet, at present no receptor for AMBN has been identified.
The effect of the recombinant N-terminus part of AMBN seems to have the opposite effect in comparison to full-length rAMBN on pre-adipocytes, reducing the expression of PPARg. In hMSC, this part of AMBN was identified to enhance the expression of RUNX2 (Stakkestad et al., 2017) . We were not able to reliably identify the ABMN N-terminus protein in mature adipocytes, however the presence of N-terminus protein as well as the secretion of various fragments of the AMBN protein from adipose tissue cannot be excluded. It can thus be speculated that the N-terminus products of AMBN promote osteoblast/osteocyte differentiation rather than have a role in adipogenesis. To our knowledge the splice variants of AMBN that exist, only differ in the inclusion or not of the 15 aa YEYSLPVHPPPLPSLQ peptide (MacDougall et al., 2000) , and the identification of the short variant in adipose tissue may not account for the lack of N-terminus signal in mature adipocytes.
AMBN C-terminus processing products are also called calcium-binding proteins Vymetal et al., 2008; Yamakoshi et al., 2001) . High levels of both extracellular and intracellular Ca 2þ have been shown to attenuate adipogenesis (Jensen et al., 2004; Shi et al., 2000) . Albeit we did not specifically study effect of e.g. AMBN knock out or silencing RNA effects on Ca 2þ effects in adipogenesis, a potential role for the AMBN C-terminus variant could be to bind and sequester Ca 2þ and prohibit mineralization of soft tissue.
AMBN gene polymorphisms (Dashash et al., 2011) , evolutionary constraints (Delsuc et al., 2015) , and knock out of exon 6 (Poulter et al., 2014) has been suggested a cause for non-functional mineralization of enamel leading to amelogenesis imperfecta. If our here proposed role for AMBN in prevention of mineralization proves true, one may surmise that loss of function could lead to e.g. ectopic mineralization of soft tissue.
Proteins that function in contact dependent cell-to-cell signaling are often immobilized in the extra cellular matrix through heparin binding domains. AMBN fits into this category of proteins as it was shown to inhibit proliferation and bind to epithelial cells dependent on heparin binding domains in the C-terminus part (Fukumoto et al., 2004; Fukumoto et al., 2005; Sonoda et al., 2009; X. Zhang et al., 2011) . AMBN as well here may remain immobilized to the cell surface of adipocytes, as it was not detected in quantitative amounts in the culture media.
The effects of AMBN in adipocytes seem analogous to effects previously reported in non-mineralizing ameloblasts, e.g. both cell types express a short AMBN splice variant, a translated AMBN C-terminus variant (Lee et al., 2003; Ravindranath et al., 2007) , and administration of rAMBN reduce proliferation (Fukumoto et al., 2004; Fukumoto et al., 2005; Kuramitsu-Fujimoto et al., 2015; Sonoda et al., 2009; Y. B. Zhang et al., 2011) . The expression or processing of AMBN in mature adipocytes may thus be similar as in ameloblast cells and the variant that retain the C-terminus end may present a novel function of AMBN in non-mineralizing tissue. The AMBN product(s) have significant biological effects in vitro on both progenitor cell differentiation and adipose cell growth. Although these results suggests that AMBN is expressed and regulated in adipose tissue, the range of samples and conditions tested are to limited to draw conclusion on to what extent AMBN is regulated, how it is regulated and what its function is. To answer these questions whether ABMN has any biological significance in adipose tissue, appropriate knock-in and knock out studies are needed complemented with a more robust set of human adipose tissue samples. However, the findings clearly show that AMBN is expressed in adipocytes, and the shared mesenchymal origin of adipose and bone cells could hint at a common function of this molecule in these tissues.
Conclusion
Adipocyte tissue expresses the C-terminus part of AMBN, probably encoded as a short splice variant. The increased expression during adipogenesis thus suggests yet another a novel previously undescribed function for AMBN variants in a nonmineralizing tissue.
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